Lifeboat Foundation

Many ophthalmologists’ offices around the country are home to a machine that enables doctors to take advantage of optical coherence tomography (OCT), a method of imaging the retina and other tissues in the eye. These OCT machines give doctors insight into the three-dimensional structures of their patients’ eyes, help them diagnose diseases and can even help save their patients’ sight.

The genesis of OCT machines began in the lab of Dr. James Fujimoto, who was inspired by advances in high-speed photography and lasers to start developing potential methods that would enable doctors to get better images of what was happening inside of people’s bodies. The goal, he told Forbes, was to develop… More.

In 1991, the trio published their first paper describing the technique they invented. “In less than a year, we were able to develop this new imaging technology, which in retrospect was pretty unusual,” Huang told Forbes.

Continue reading “Retinal Imaging And Machine Learning Honored In The 2023 Lasker Awards” »

DeepMind has released a catalog of 71 million possible variants that can cause diseases.

Genetic mutations are changes to our DNA sequence. This happens when cells make copies of themselves during cell division. Mutation is the ultimate source of human genetic variation and has evolutionary and disease genetics implications. A mutation affecting our genes might give birth to a genetic disorder. But just because you have a mutation doesn’t mean it will be a genetic disorder.

That is why researchers at DeepMind, the artificial intelligence arm of Google, have announced that they have trained a machine learning model called AlphaMissense to classify which DNA variations in our genomes are likely to cause disease.

Past tests have been conducted on pigs.

On Tuesday, Elon Musk’s Neuralink announced it was ready to start its first human trials. “We are happy to announce that we’ve received approval from the reviewing independent institutional review board and our first hospital site to begin recruitment for our first-in-human clinical trial,” noted a blog on the company’s website.

The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for… More.

Continue reading “Neuralink to recruit people with paralysis for first human trials” »

As befits the child of a scientist, Martin Picard’s young son, 3, is already learning about biology with an age-appropriate textbook, “Cell Biology for Babies.” Picard winces a little whenever the book calls mitochondria the “powerhouses of the cell” but figures he has plenty of time as his son grows older to explain why the tiny organelles are much more than simple energy sources.

Picard is a leading proponent of mitochondrial psychobiology (a phrase he coined), an emerging field that examines how psychological states like stress influence mitochondrial functions, which in turn influence mental and physical health.

Continue reading “Exploring the mind-mitochondria connection” »

Google DeepMind has used its technology to identify parts of human DNA that might cause diseases.

A virtual cell modeling system, powered by AI, will lead to breakthroughs in our understanding of diseases, argue the cofounders of the Chan Zuckerberg Initiative.

As the smallest living units, cells are key to understanding disease—and yet so much about them remains unknown. We do not know, for example, how billions of biomolecules—like DNA, proteins, and lipids—come together to act as one cell. Nor do we know how our many types of cells interact within our bodies. We have limited understanding of how cells, tissues, and organs become diseased and what it takes for them to be healthy.

AI can help us answer these questions and apply that knowledge to improve health and well-being worldwide—if… More.

CHOP researchers established the feasibility of an artificial womb called the “Biobag” to nurture a premature lamb in 2017.

The US Food and Drug Administration (FDA) will hold a meeting of independent advisors on September 19–20. The meeting’s agenda is to discuss the viability of clinical trials using artificial womb technology to improve the survival and health of extremely preterm newborns.

Continue reading “Artificial womb human trials may soon inch closer to reality” »

An international clinical trial exploring a new way to treat rare and aggressive gynaecological cancers has launched in Melbourne.

Get my FREE guide 3 Steps to Reverse Aging when you sign up for my weekly health picks 👉 https://bit.ly/IncreaseHealthspan.

There is powerful science behind how our beliefs inform our genetic expression. It’s not our genes alone that dictate our health outcomes, rather it’s the biology of belief that determines our destiny.

Continue reading “How Our GENES Listen To Our Beliefs: Heal The Body & Prevent Disease | Dr. Bruce Lipton” »